Fluvastatin enhances receptor-stimulated intracellular Ca2+ release in human keratinocytes

Biochem Biophys Res Commun. 1998 Apr 17;245(2):307-12. doi: 10.1006/bbrc.1998.8429.

Abstract

We analyzed the effect of isoprenoid depletion by fluvastatin on bradykinin (BK)- and epidermal growth factor (EGF)-mediated Ca2+ mobilization and prostaglandin E2 production, in the human keratinocyte cell line HaCaT. BK and EGF stimulated Ca2+ mobilization in an agonist-dependent manner. The synthesis of prostaglandin E2 paralleled the level of Ca2+ mobilization induced by BK and EGF. Treatment with fluvastatin increased the EGF-promoted but not the BK-promoted Ca2+ mobilization and prostaglandin E2 production in Ca(2+)-containing medium. In the absence of extracellular Ca2+, fluvastatin treatment led to an increase in intracellular Ca2+ release by both agonists. This effect was abolished by depleting the intracellular pool of Ca2+ with thapsigargin. Our findings showed that the intracellular Ca2+ release was dependent on the metabolism of mevalonate and that the Ca2+ mobilization modulated prostaglandin E2 synthesis in human keratinocytes.

MeSH terms

  • Aniline Compounds / metabolism
  • Bradykinin / pharmacology
  • Calcium / metabolism*
  • Cell Line
  • Dinoprostone / biosynthesis
  • Epidermal Growth Factor / pharmacology
  • Fatty Acids, Monounsaturated / pharmacology*
  • Fluvastatin
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Indoles / pharmacology*
  • Keratinocytes / drug effects*
  • Kinetics
  • Mevalonic Acid / metabolism
  • Thapsigargin / pharmacology
  • Xanthenes / metabolism

Substances

  • Aniline Compounds
  • Fatty Acids, Monounsaturated
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Indoles
  • Xanthenes
  • Fluo-3
  • Fluvastatin
  • Epidermal Growth Factor
  • Thapsigargin
  • Dinoprostone
  • Mevalonic Acid
  • Bradykinin
  • Calcium